Gutting the brain of inflammation: A key role of gut microbiome in human umbilical cord blood plasma therapy in Parkinson's disease model

Current therapies for Parkinson's disease (PD), including L‐3,4‐dihydroxyphenylalanine (L‐DOPA), and clinical trials investigating dopaminergic cell transplants, have generated mixed results with the eventual induction of dyskinetic side effects. Although human umbilical cord blood (hUCB) stem/...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jea‐Young, Tuazon, Julian P., Ehrhart, Jared, Sanberg, Paul R., Borlongan, Cesario V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653272/
https://www.ncbi.nlm.nih.gov/pubmed/31148353
http://dx.doi.org/10.1111/jcmm.14429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6653272/
https://www.ncbi.nlm.nih.gov/pubmed/31148353
http://dx.doi.org/10.1111/jcmm.14429

Ejemplares similares